Tengjun Biotechnology Corp.
Tengjun Biotechnology Corp. (TJBH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
tjbh · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Tengjun Biotechnology Corp. (TJBH) measures how much investors pay for each dollar of the company's trailing earnings. TJBH's current PE ratio of 14.13x is calculated by dividing its stock price of $2.00 by its TTM earnings per share of $0.14. −55.5% discount vs 5Y avg 31.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2011 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Packaged Foods · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Tengjun Biotechnology Corp.You TJBH | $201M | 14.13x | +11.6% | $0.14 |
 Andrew Peller Limited ADWPF | $174M | 15.82x | +25.0% | $0.30 |
 Bubs Australia Limited BUBSF | $69M | 22.03x | +74.0% | $0.01 |
 Casino, Guichard-Perrachon S.A. CGUIF | $91M | N/A | — | -$2.73 |
 Comvita Limited CVNZF | $30M | N/A | — | -$1.49 |
 Dundee Corporation DDEJF | $225M | 0.78x | -93.8% | $4.90 |
 South Dakota Soybean Processors, LLC SDSYA | $207M | 12.00x | -5.2% | $0.58 |
Industry Average 4 peers with valid PE | — | 12.66x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | 31.79x | $0.14 | — | |
2021-12-31 FY2021 | — | $-0.01 | — | |
2020-12-31 FY2020 | — | $-0.01 | — | |
2019-12-31 FY2019 | — | $-0.00 | — | |
2018-12-31 FY2018 | — | $-0.00 | — | |
2017-12-31 FY2017 | — | $-0.00 | — | |
2016-12-31 FY2016 | — | $-0.00 | — | |
2015-12-31 FY2015 | — | $-0.00 | — | |
2014-12-31 FY2014 | — | $-0.00 | — | |
2013-12-31 FY2013 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Tengjun Biotechnology Corp. (TJBH) measures how much investors pay for each dollar of the company's trailing earnings. TJBH's current PE ratio of 14.13x is calculated by dividing its stock price of $2.00 by its TTM earnings per share of $0.14.
Frequently asked questions
TJBH pe ratio · 6 questionsTJBH's current PE ratio is 14.13x as of 2026-06-09, based on a stock price of $2.00 and TTM EPS of $0.14. Data sourced from Financial Modeling Prep via TJBH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Tengjun Biotechnology Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09